Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000293545 | SCV000391266 | uncertain significance | Spastic Paraplegia, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000604740 | SCV000715399 | likely benign | not specified | 2017-12-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome Diagnostics Laboratory, |
RCV000625161 | SCV000743943 | likely benign | Hereditary spastic paraplegia 11 | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625161 | SCV001719718 | benign | Hereditary spastic paraplegia 11 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529987 | SCV002545245 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | SPG11: BS2 |
Genome Diagnostics Laboratory, |
RCV000625161 | SCV000745903 | likely benign | Hereditary spastic paraplegia 11 | 2016-09-21 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001529987 | SCV001744417 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000604740 | SCV001806799 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001529987 | SCV001919574 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003930353 | SCV004741967 | likely benign | SPG11-related disorder | 2019-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |